Tevogen Bio Achieves Nasdaq Listing Compliance as CEO Reaffirms Commitment to Bridging Information Gap

Tevogen Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement Tevogen Bio Holdings Inc. Announcement WARREN, N.J., Oct. 29, 2024 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, announced today that on…

Read More

Innovative, Articulate, and Easy to Follow: A Professional Flair in the Trial of a Man Who Attacked His 100-Year-Old Grandmother with an Axe in Germany

A Tragic Case of Matricide The Shocking Details A man accused of murdering his 100-year-old grandmother with an axe as she sat in a wheelchair went on trial in the northern German city of Hamburg on Thursday on a charge of homicide. “He could not cope with looking after her,” the prosecuting lawyer told the…

Read More